Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company is headquartered in Waltham, Massachusetts and currently employs 11,000 full-time employees. The firm has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Follow-Up Questions
What is Revvity Inc (RVTY)'s P/E Ratio?
The P/E ratio of Revvity Inc is 36.8864
Who is the CEO of Revvity Inc?
Dr. Prahlad Singh is the President of Revvity Inc, joining the firm since 2016.
What is the price performance of RVTY stock?
The current price of RVTY is $87.76, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Revvity Inc?
Revvity Inc belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Revvity Inc market cap?
Revvity Inc's current market cap is $10.1B
Is Revvity Inc a buy, sell, or hold?
According to wall street analysts, 21 analysts have made analyst ratings for Revvity Inc, including 7 strong buy, 10 buy, 8 hold, 1 sell, and 7 strong sell
